Navigo Proteins creates innovation for next generation products that have best-in-class potential. We initiate our lead discovery on behalf of our partners or on the basis of own internally invented concepts. Our commercial strategy is founded on a strong and undisputed IP position that provides freedom to operate and full patentability of any derived products. The commercial prospect of our company is based on service fee arrangements and/ or royalty components in our partnerships.

Contact Information:

Precision Capturing:
Custom-developed affinity protein ligands for purifying antibodies and non-antibody, viral, cellular and other complex biotherapeutics

as well as

Precision Targeting:
Tailor-made, targeting protein carriers for therapeutic and diagnostics medicines.

Dr. Oliver Schub
Director Business Development
Oliver joined Navigo in 2018 to lead Navigo’s Business Development Department. He is globally well connected with biotech and pharma companies and has a track record of therapeutic protein development deals in all parts of the world. Oliver has more than 14 years of experience in various academic and industry labs in cell culture, protein expression, purification and characterization. In addition, he gained 13 years of professional biotech experience in various positions. Before joining Navigo he was Senior Business Development Manager at ProBioGen AG in Berlin, a globally operating Contract Development and Manufacturing Organization (CDMO) for vertebrate cell culture-based biotherapeutics. Before that he worked at PSF Biotech (“Protein Structure Factory”) as laboratory head in structure-based drug design and later BD Head. During his academic career he was a postdoctoral fellow at the University of Toronto, working on eukaryotic cell cycle control. Oliver holds a PhD in biochemistry from the Genzentrum of LMU Munich and the Institute for Molecular Biotechnology of Friedrich Schiller University in Jena. Oliver is a chemist by education (University Regensburg) with a diploma thesis in protein folding.
Dr. Florian Settele
Head of Business Unit Precision Capturing
»Navigo Proteins’ aim is to deliver optimal solutions for the varying goals of our customers from different fields of the industry. Precise project coordination with our partners is crucial for every successful project. As Manager Commercial Alliances it is my goal to guide our partners through product development with open and transparent communication to reach the best possible outcome efficiently.«

Florian joined Navigo Proteins in 2011 as a scientist, first responsible for the selection of lead candidates by phage display. After developing into Project Coordinator from 2015-2017 for numerous external projects he became Manager Commercial Alliances in 2017, being responsible for all external project communication and coordination with our partners. Florian received his PhD in Cell and Molecular Biology at the German Cancer Research Institute (DKFZ) in Heidelberg and is currently attending a part-time MBA program at the Handelshochschule Leipzig (HHL).